Jing Du

3.4k total citations · 1 hit paper
53 papers, 1.8k citations indexed

About

Jing Du is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Jing Du has authored 53 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 16 papers in Cancer Research and 11 papers in Immunology. Recurrent topics in Jing Du's work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers) and Cancer Cells and Metastasis (4 papers). Jing Du is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers) and Cancer Cells and Metastasis (4 papers). Jing Du collaborates with scholars based in China, Hong Kong and Germany. Jing Du's co-authors include Lijuan Yang, Juanjuan Dai, Kaikai Gong, Jiwei Guo, Shuang Miao, Weiwei Chen, Yan Wu, George G. Chen, Dan Jin and Calvin S.H. Ng and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Jing Du

49 papers receiving 1.7k citations

Hit Papers

m6A demethylase ALKBH5 inhibits tumor growth and metastas... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Du China 20 1.0k 535 376 313 136 53 1.8k
Fang Ding China 25 1.2k 1.1× 573 1.1× 209 0.6× 393 1.3× 154 1.1× 78 1.8k
Patrícia A. Madureira Portugal 21 1.1k 1.1× 512 1.0× 295 0.8× 293 0.9× 137 1.0× 29 1.7k
Qianghu Wang China 22 1.1k 1.1× 649 1.2× 222 0.6× 406 1.3× 256 1.9× 59 2.1k
Sonia V. del Rincón Canada 23 1.3k 1.3× 309 0.6× 456 1.2× 731 2.3× 152 1.1× 59 2.1k
Shulan Zhang China 25 851 0.8× 358 0.7× 457 1.2× 332 1.1× 67 0.5× 96 1.7k
Kai Xue China 23 872 0.9× 436 0.8× 182 0.5× 333 1.1× 140 1.0× 104 1.7k
Adriana Aguilar‐Mahecha Canada 19 835 0.8× 637 1.2× 213 0.6× 420 1.3× 169 1.2× 43 1.7k
Ying‐Hui Zhu China 20 821 0.8× 464 0.9× 200 0.5× 281 0.9× 173 1.3× 49 1.3k
Dorina Gui United States 23 862 0.9× 243 0.5× 211 0.6× 345 1.1× 166 1.2× 52 1.7k

Countries citing papers authored by Jing Du

Since Specialization
Citations

This map shows the geographic impact of Jing Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Du more than expected).

Fields of papers citing papers by Jing Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Du. The network helps show where Jing Du may publish in the future.

Co-authorship network of co-authors of Jing Du

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Du. A scholar is included among the top collaborators of Jing Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Du. Jing Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Cuilan, Bingjie Cui, Weiwei Chen, et al.. (2025). Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression. Cancer Research. 85(13). 2429–2447. 6 indexed citations
3.
Xia, Yuhao, Qian Li, Jiahao Wen, et al.. (2024). Metallothionein-1 mitigates the advancement of osteoarthritis by regulating Th17/Treg balance. Cellular Immunology. 405-406. 104877–104877. 7 indexed citations
4.
Zhang, Shuo, Fengjiao Sun, Weiwei Chen, et al.. (2024). Anti-angiogenesis and anti-immunosuppression gene therapy through targeting COUP-TFII in an in situ glioblastoma mouse model. Cancer Gene Therapy. 31(8). 1135–1150. 2 indexed citations
5.
Dong, Hongliang, Weiwei Chen, Qian Zhang, et al.. (2023). N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness. Cell Death Discovery. 9(1). 149–149. 19 indexed citations
6.
Li, Wanlin, Jing Du, Jing Hu, et al.. (2023). Increased expression of long-isoform thymic stromal lymphopoietin is associated with rheumatoid arthritis and fosters inflammatory responses. Frontiers in Immunology. 13. 1079415–1079415. 3 indexed citations
7.
Wang, Wenlong, Zhipeng Li, Fang Wang, et al.. (2023). Integrated analysis of high‑throughput sequencing reveals the regulatory potential of hsa_circ_0035431 in HNSCC. Oncology Letters. 26(4). 435–435. 3 indexed citations
8.
Du, Jing, et al.. (2022). Thinking of change in times of danger: The differential impact of job insecurity on innovative behavior. Advances in Psychological Science. 30(11). 2381–2381.
9.
Yu, Zitong, Rui Hao, Jing Du, et al.. (2022). A human cornea-on-a-chip for the study of epithelial wound healing by extracellular vesicles. iScience. 25(5). 104200–104200. 36 indexed citations
10.
Dai, Juanjuan, Rui Wu, Jing Du, et al.. (2021). LncRNA MALAT1 Regulating Lung Carcinoma Progression via the miR-491-5p/UBE2C Axis. Pathology & Oncology Research. 27. 610159–610159. 9 indexed citations
11.
Chen, Weiwei, Kaikai Gong, Lijuan Yang, et al.. (2020). Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2/SMO/GLI1 network loop. Journal of Ethnopharmacology. 265. 113295–113295. 12 indexed citations
12.
Chen, Weiwei, Jiajia An, Jiwei Guo, et al.. (2018). Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness. Cancer Chemotherapy and Pharmacology. 81(5). 885–895. 19 indexed citations
13.
Yang, Shucai, Yi Liu, Mingyue Li, et al.. (2017). FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer. Molecular Cancer. 16(1). 124–124. 328 indexed citations
14.
Du, Jing, Weiwei Chen, Lijuan Yang, et al.. (2017). Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment. Scientific Reports. 7(1). 1899–1899. 20 indexed citations
15.
Wang, Shanshan, Alexander C. Vlantis, Enders K. Ng, et al.. (2016). Expression of Antioxidant Molecules and Heat Shock Protein 27 in Thyroid Tumors. Journal of Cellular Biochemistry. 117(11). 2473–2481. 17 indexed citations
17.
Shao, Bin, Xiawei Wei, Min Luo, et al.. (2015). Inhibition of A20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis. Scientific Reports. 5(1). 16437–16437. 17 indexed citations
18.
Chu, Ryan, Alexander C. Vlantis, C. Andrew van Hasselt, et al.. (2014). Inhibition of Foxp3 in cancer cells induces apoptosis of thyroid cancer cells. Molecular and Cellular Endocrinology. 399. 228–234. 44 indexed citations
19.
Liu, Pan, Xiuping Wu, Chengshui Liao, et al.. (2014). Escherichia coli and Candida albicans Induced Macrophage Extracellular Trap-Like Structures with Limited Microbicidal Activity. PLoS ONE. 9(2). e90042–e90042. 106 indexed citations
20.
Du, Jing, et al.. (2011). Octarepeat peptides of prion are essential for multidrug resistance in gastric cancer cells. Journal of Digestive Diseases. 13(3). 143–152. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026